Evidence map›Paper›PMID 39854355›Full record

ArticlePloS one2025

Respiratory extracellular vesicle isolation optimization through proteomic profiling of equine samples and identification of candidates for cell-of-origin studies.

Elise Hickman, Victoria Carberry, Celeste Carberry, Bethanie Cooper, Angie L Mordant, Allie Mills, Marina Sokolsky, Laura E Herring, Neil E Alexis, Meghan E Rebuli and 3 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Elise HickmanCurriculum in Toxicology & Environmental Medicine, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID 0000-0001-6152-050X
Victoria CarberryDepartment of Environmental Sciences and Engineering, Gillings School of Global Public Health, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Celeste CarberryDepartment of Environmental Sciences and Engineering, Gillings School of Global Public Health, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Bethanie CooperDepartment of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, United States of America.ORCID 0000-0002-1251-1866
Angie L MordantUNC Michael Hooker Proteomics Core, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Allie MillsUNC Michael Hooker Proteomics Core, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Marina SokolskyCenter for Nanotechnology in Drug Delivery, UNC School of Medicine, Chapel Hill, North Carolina, United States of America.
Laura E HerringUNC Michael Hooker Proteomics Core, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Neil E AlexisCurriculum in Toxicology & Environmental Medicine, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Meghan E RebuliCurriculum in Toxicology & Environmental Medicine, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Ilona JaspersCurriculum in Toxicology & Environmental Medicine, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.
Katie SheatsDepartment of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, United States of America.ORCID 0000-0002-5270-4566
Julia E RagerCurriculum in Toxicology & Environmental Medicine, UNC Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID 0000-0002-2882-5042

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JAMES E BEAR · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Kelly Sides · 2015 to 2026
$18.3M
TOXICOLOGYT32ES007126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ILONA JASPERS, Bernard E. Weissman · 1985 to 2026
$13.0M
Wildland Urban Interface Exposure Toxicity in Cells, Animals, and HumansR01ES035878 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Julia Rager · 2024 to 2026
$2.2M
Mechanisms of wildfire smoke toxicity and susceptibility involving extracellular vesicles in humansF32ES036096 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HICKMAN, ELISE DANIELLE · 2024 to 2024
$74k
NCI NIH HHS P30 CA016086NIEHS NIH HHS F32 ES036096NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P30 ES025128NIEHS NIH HHS R01 ES035878NIEHS NIH HHS T32 ES007126
6 · The paper itself

Abstract

Growing evidence supports the importance of extracellular vesicle (EV) as mediators of communication in pathological processes, including those underlying respiratory disease. However, establishing methods for isolating and characterizing EVs remains challenging, particularly for respiratory samples. This study set out to address this challenge by comparing different EV isolation methods and evaluating their impacts on EV yield, markers of purity, and proteomic signatures, utilizing equine/horse bronchoalveolar lavage samples. Horses can serve as effective translational animal models for respiratory studies due to similarities with human immune responses, shared environmental exposures, and naturally occurring respiratory diseases including asthma. Further, horses are long-lived large animals that allow for longitudinal sample collection, and provide large sample volume and cell yield, which are particularly useful since EV research is commonly limited by low sample yields. Here, EVs were isolated from horse bronchoalveolar lavage fluid (BALF) using four different methods (ultracentrifugation, microcentrifugation, and two sizes of size exclusion chromatography columns) and characterized by measuring particle counts, EV purity, total protein yield, and proteomic cargo, with a specific focus on vesicle surface marker expression potentially informing cell type of origin. We found that size exclusion chromatography yielded the highest particle counts, greatest EV purity markers and elevated vesicle surface marker expression. Overall proteomic profiles differed across isolation methods, with size exclusion chromatography clustering separately from centrifugation. Taken together, our results demonstrate that different isolation methods impact characteristics of EVs, notably that size exclusion chromatography, compared to centrifugation methods, resulted in higher EV purity and better characterized proteomic diversity, including information on EV cell-of-origin. This is the first study to characterize proteomic profiles of EVs following different isolation methods using equine BALF. The results of this study will pave the way for future studies using equine and human samples to characterize respiratory tract EVs.

Indexed as

Extracellular VesiclesProteomeProteomicsAnimalsBiomarkersBronchoalveolar Lavage FluidChromatography, GelHorsesBiomarkersProteome

Identifiers

PMID39854355
PMCPMC11760557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.